期刊文献+

免疫细胞化学法检测羟基喜树碱对乳腺癌MCF-7细胞的TIMP-3及空泡化作用 被引量:2

The detection of the TIMP-3 expression and the cellular vaculization induced by HCPT detected with immunocytochemical method
暂未订购
导出
摘要 目的探索羟基喜树碱对乳腺癌细胞MCF-7细胞信号转导相关基因TIMP-3表达,观察羟基喜树碱处理乳腺癌细胞MCF-7细胞形态的改变,从而探讨羟基喜树碱在乳腺癌治疗中的潜在新靶点。方法以乳腺癌细胞MCF-7为研究模型,细胞暴露于羟基喜树碱浓度为10、40、80mg/L的培养液中24h,PBS组为对照组。采用免疫组化法检测羟基喜树碱(HCPT)对乳腺癌MCF-7细胞TIMP-3表达特征及细胞形态的变化。结果 HCPT对TIMP-3诱导表达作用差异不明显,但HCPT处理组细胞呈现明显的空泡化。结论 HCPT可诱导乳腺癌MCF-7细胞空泡化作用。 Objective To explore the different concentration of HCPT effects on TIMP-3 expression in breast tomor cell line MCF-7 and the shapes of MCF-7 cells were observed in this paper. Methods MCF-7 cell cultures were exposed to HCPT at concentrations of 10, 40, 80 mg/L for 24 h. PBS group as control group. Immunocytochemical method was used to measure the TIMP-3 expression in breast tomor cell line MCF-7 and the shapes of MCF-7 cells for each sample. Results The upregulated expression of TIMP-3 in the MCF-7 cell line could not be obviously induced by different concentration of HCPT, but the obvious presentation of the cellular vaculization could be induced by the cells of the disposed guoup of HCPT. Conclusion The cellular vaculization for MCF-7 cells can be induced by HCPT.
作者 蒲锦兰 周滢
出处 《中国当代医药》 2012年第25期7-8,共2页 China Modern Medicine
基金 重庆市卫生局中医药科技计划项目(NO:2010-2-66)
关键词 羟基喜树碱 空泡化 免疫细胞化学法 金属蛋白酶组织抑制剂-3 HCPT Cellular vaculization Immunocytochemical method TIMP-3
  • 相关文献

参考文献8

  • 1Ling YH ,Tseng MT,Nelson JA. Differentiation induction of human promye- locytic leukemia cells by 10-hydroxycamptothecin,a DNA topoisomerase I inhibitor[J]. Differentiation, 1991,46(2) : 135-141.
  • 2叶孟,林蕾,方勇,潘宏铭,吴金民.Bay117802抑制羟基喜树碱诱导的人乳腺癌Bcap37细胞凋亡[J].中国临床药理学与治疗学,2005,10(7):755-759. 被引量:3
  • 3叶孟,林蕾,方勇,潘宏铭,吴金民.羟基喜树碱依赖Caspase3途径诱导人乳腺癌Bcap37细胞凋亡[J].中国临床药理学与治疗学,2005,10(8):881-884. 被引量:6
  • 4Liu W,Zhang R. Upregulation of p21WAF1/C1P1 in human breast can- cer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camp- tothecin through p53-dependent and independent pathways[J], lnt J On- col, 1998,12(4) :793-804.
  • 5Uria JA,Ferrando AA,Velasco G,et al. Structure and expression in breast tumors of human TIMP-3,a new member of the metalloproteinase inhibitor family. Structure and expression in breast tumors of human TIMP-3,a new member of the metalloproteinase inhibitor family[J]. Can- cer Res, 1994,54(8) :2091-2094.
  • 6Finan KM,Hodge G,Reynolds AM,et al. In vitro susceptibility to the pro-apoptotic effects of TIMP-3 gene delivery translates to greater in vivo efficacy versus gene delivery for TIMPs-1 or -2[J]. Lung Cancer,2006,53 (3) :273-284.
  • 7Galvez-Peralta M,Dai NT,Loegering DA,et al. Overcoming S-phase checkpoint-mediated resistance: sequence-dependent synergy of gemc- itabine and 7-ethyl-10-hydroxycamptothecin (SN-38) in human carci- noma cell lines[J]. Mol Pharmaeol, 2008,74 (3) : 724-735.
  • 8周萍,汪洋,付利娟.羟基喜树碱对乳腺癌细胞MCF-7细胞信号转导相关基因的影响[J].西南大学学报(自然科学版),2010,32(8):58-63. 被引量:3

二级参考文献35

  • 1叶孟,林蕾,方勇,潘宏铭,吴金民.Bay117802抑制羟基喜树碱诱导的人乳腺癌Bcap37细胞凋亡[J].中国临床药理学与治疗学,2005,10(7):755-759. 被引量:3
  • 2Tao Y, Pinzi V, Bourhis J, et al. Mechanisms of Disease: Signaling of the Insulin- Like Growth Factor 1 Receptor Pathway Therapeutic Perspectives in Cancer [J]. Nat Clin Pract Oncol, 2007, 4(10): 591-602.
  • 3Gangavarapu K J, Olbertz J L, Bhushan A, et al. Apoptotic Resistance Exhibited by Dexamethasone-Resistant Murine 7TD1 Cells is Controlled Independently of Interleukin- 6 Triggered Signaling [J]. Apoptosis, 2008, 13 (11) : 1394 - 1400.
  • 4Ling Y H, Tseng M T, Nelson J A. Differentiation Induction of Human Promyelocytic Leukemia Cells by 10 Hydroxycamptothecin, a DNA Topoisomerase I Inhibitor[J]. Differentiation, 199i, 46(2) : 135 - 141.
  • 5Hsiang Y H, Liu L F. Identification of Mammalian DNA Topoisomerase I as an Intracellular Target of the Anticancer Drug Camptothecin [J]. Cancer Res, 1988, 48(7) : 1722 - 1726.
  • 6Downward J. Targeting RAS Signalling Pathways in Cancer Therapy [J]. Nat Rev Cancer, 2003, 3:11 -22.
  • 7Mylona E, Magkou C, Giannopoulou I, et al. Expression of Tissue Inhibitor of Matrix Metalloproteinases (TIMP)-3 Protein in Invasive Breast Carcinoma: Relation to Tumor Phenotype and Clinical Outcome [J]. Breast Cancer Res, 2006,8(5): 57.
  • 8Cummings J, Boyd G, Ethell B T, et al. Enhanced Clearance of Topoisomerase I Inhibitors from Human Colon Cancer Cells by Glucuronidation [J]. Biochem Pharmacol, 2002, 63(4): 607- 613.
  • 9Zhang X W, Xu B. Differential Regulation of P53, c-Myc, Bcl- 2, Bax and AFP Protein Expression, and Caspase Activity During 10- Hydroxycamptothecin-Induced Apoptosisin Hep G2 Cells [J]. Anticancer Drugs, 2000, 11(9): 747 -756.
  • 10Fu Y R, Yi Z J, Yan Y R, et al. Hydroxycamptothecin-Inducecl Apoptosis in Hepatoma SMMC-7721 Cells and the Role of MitochondrialPathway [J]. Mitochondrion, 2006, 6(4): 211-217.

共引文献7

同被引文献28

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部